Moreover, our results also demonstrate that the levels of ANXA2 in purified EVs from the plasma of EC patients correlate with the tumor histology, grade, stage, and risk of recurrence, reinforcing their interest as a marker linked to more aggressive tumors. The gene discussed is ANXA2; the disease is neoplasm.